Nelarabine Injection
Product Images NDC 70121-1743

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 70121-1743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Nelarabine Injection 1)

Chemical structure of nelarabine, showing its molecular components including nitrogen, oxygen, and hydroxyl groups, consistent with the active ingredient nelarabine in the injectable drug by Amneal Pharmaceuticals LLC.*

FDA Label Image

1 (Nelarabine Injection 2)

Nelarabine Injection 250 mg/50 mL (5 mg/mL) label for intravenous infusion only, manufactured by Amneal Pharmaceuticals LLC. The single-dose vial contains Nelarabine and various inactive ingredients. Storage and usage instructions are included, along with barcodes and an area reserved for lot and expiration details.*

FDA Label Image

1 (Nelarabine Injection 3)

Packaging label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous infusion, supplied as six 50 mL single-dose vials. Label designates it as a cytotoxic agent and notes discard of unused portions. Manufactured by Amneal Oncology Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. Contains storage and usage instructions, ingredients, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.